ZBTB20 and hepatocellular carcinoma: Furthermore, luciferase reporter assay showed that ZBTB20 overexpression dramatically repressed Afp promoter activity in hepatocellular carcinoma cells HepG2 as a positive control, but had no significant effect on the transcriptional activity of a mouse Egfr promoter (spanning 3.7-kb upstream transcriptional start site).